Waduge P - Search Results

1

Comparative ligandomics implicates secretogranin III as a disease-restricted angiogenic factor in laser-induced choroidal neovascularization.

Ji L, Waduge P, Wan W, Tian H, Li J, Zhang J, Chen R, Li W. Ji L, et al. Among authors: waduge p. FEBS J. 2022 Jun;289(12):3521-3534. doi: 10.1111/febs.16356. Epub 2022 Feb 1. FEBS J. 2022. PMID: 35038348 Free PMC article.

2

Selectively targeting disease-restricted secretogranin III to alleviate choroidal neovascularization.

Ji L, Waduge P, Hao L, Kaur A, Wan W, Wu Y, Tian H, Zhang J, Webster KA, Li W. Ji L, et al. Among authors: waduge p. FASEB J. 2022 Jan;36(1):e22106. doi: 10.1096/fj.202101085RR. FASEB J. 2022. PMID: 34918375 Free PMC article.

3

Secretogranin III stringently regulates pathological but not physiological angiogenesis in oxygen-induced retinopathy.

Dai C, Waduge P, Ji L, Huang C, He Y, Tian H, Zuniga-Sanchez E, Bhatt A, Pang IH, Su G, Webster KA, Li W. Dai C, et al. Among authors: waduge p. Cell Mol Life Sci. 2022 Jan 10;79(1):63. doi: 10.1007/s00018-021-04111-2. Cell Mol Life Sci. 2022. PMID: 35006382 Free PMC article.

4

Profiling disease-selective drug targets: From proteomics to ligandomics.

Waduge P, Tian H, Webster KA, Li W. Waduge P, et al. Drug Discov Today. 2023 Mar;28(3):103430. doi: 10.1016/j.drudis.2022.103430. Epub 2022 Nov 4. Drug Discov Today. 2023. PMID: 36343915 Free PMC article. Review.

5

Secretogranin III Selectively Promotes Vascular Leakage in the Deep Vascular Plexus of Diabetic Retinopathy.

Ji L, Waduge P, Wu Y, Huang C, Kaur A, Oliveira P, Tian H, Zhang J, Stout JT, Weng CY, Webster KA, Li W. Ji L, et al. Among authors: waduge p. Int J Mol Sci. 2023 Jun 23;24(13):10531. doi: 10.3390/ijms241310531. Int J Mol Sci. 2023. PMID: 37445707 Free PMC article.

6

Anti-Scg3 Gene Therapy to Treat Choroidal Neovascularization in Mice.

Huang C, Ji L, Kaur A, Tian H, Waduge P, Webster KA, Li W. Huang C, et al. Among authors: waduge p. Biomedicines. 2023 Jul 6;11(7):1910. doi: 10.3390/biomedicines11071910. Biomedicines. 2023. PMID: 37509549 Free PMC article.

7

Optimal Humanized Scg3-Neutralizing Antibodies for Anti-Angiogenic Therapy of Diabetic Retinopathy.

Huang C, Waduge P, Kaur A, Tian H, Weng CY, Stout JT, Pang IH, Webster KA, Li W. Huang C, et al. Among authors: waduge p. Int J Mol Sci. 2024 Sep 1;25(17):9507. doi: 10.3390/ijms25179507. Int J Mol Sci. 2024. PMID: 39273454 Free PMC article.

8

A method for rapid and reliable quantification of VEGF-cell binding activity.

Waduge P, Kaur A, Li W. Waduge P, et al. Biochem Biophys Res Commun. 2024 Oct 1;727:150321. doi: 10.1016/j.bbrc.2024.150321. Epub 2024 Jun 27. Biochem Biophys Res Commun. 2024. PMID: 38954982 Free article.

9

An Advanced Apralog with Increased in vitro and in vivo Activity toward Gram-negative Pathogens and Reduced ex vivo Cochleotoxicity.

Sonousi A, Quirke JCK, Waduge P, Janusic T, Gysin M, Haldimann K, Xu S, Hobbie SN, Sha SH, Schacht J, Chow CS, Vasella A, Böttger EC, Crich D. Sonousi A, et al. Among authors: waduge p. ChemMedChem. 2021 Jan 19;16(2):335-339. doi: 10.1002/cmdc.202000726. Epub 2020 Oct 23. ChemMedChem. 2021. PMID: 33007139 Free PMC article.

10

Use of a fluorescence assay to determine relative affinities of semisynthetic aminoglycosides to small RNAs representing bacterial and mitochondrial A sites.

Waduge P, Sati GC, Crich D, Chow CS. Waduge P, et al. Bioorg Med Chem. 2019 Nov 15;27(22):115121. doi: 10.1016/j.bmc.2019.115121. Epub 2019 Sep 13. Bioorg Med Chem. 2019. PMID: 31610941 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters